Forbes.com: Cancer Therapeutics Laboratories Files Cross – Complaint Against Licensor for Return of Cancer Therapy Technology

Stan Gibson was quoted in Forbes.com and Genetic Engineering and Biotechnology News on March 29, 2007 in an article titled, "Cancer Therapeutics Laboratories Files Cross – Complaint Against Licensor for Return of Cancer Therapy Technology."